跳至主要内容
临床试验/CTRI/2025/04/083928
CTRI/2025/04/083928尚未招募不适用

Comparative clinical study to evaluate the efficacy of Gud-Pippalimool tablet and Ashwagandha tablet in the management of Nidranash w.r.t Insomnia

Dr Tanya Bhawnani1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年4月10日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
The drug may help to bring Improvement in sleep Quality and duration

研究概览

简要总结

Title: Comparative Clinical Study to evaluate the efficacy of Gud-Pippalimool tablet and Ashwagandha Tablet in the Management of Nidranash w.r.t Insomnia

Aim: To compare the efficacy of Gud-Pippalimool tablet and Ashwagandha tablet in the management of Nidranash w.r.t Insomnia.

Objectives: 1. To study the effect of Gud-Pippalimool tablet in management of Insomnia. 2. To study insomnia in detail according to Ayurveda and modern science. 3. To compare the effects of Gud-Pippalimool tablet and Ashwagandha tablet in the management of insomnia.

Research Questions: Primary Research Question - Is Gud-Pippalimool tablet effective in the management of Nidranash w.r.t Insomnia? Secondary Research Question - Is the effect of Gud-Pippalimool tablet significant than Ashwagandha tablet in the management of Nidranash w.r.t Insomnia?

Hypothesis: H0: There will be no significant difference between Gud-Pippalimool tablet and Ashwagandha tablet in the management of Nidranash w.r.t Insomnia. H1: There will be significant difference between Gud-Pippalimool tablet and Ashwagandha tablet in the management of Nidranash w.r.t Insomnia.

Materials: Group A (Gud-Pippalimool tablet) - Contents: Pippali, Pippali Mool and Gud (Jaggery). Group B (Ashwagandha Tablet) - Contents: Ashwagandha churna, Sita (sugar) and Sarpi (ghee).

Drug Administration: Gud-Pippalimool tablet 2gm HS with water for 28 days by oral route and Ashwagandha tablet 2gm HS with water for 28 days by oral route.

Methods: Study Design - Two arms, Open labelled, Randomized and Controlled clinical study.

Assessment Criteria: Subjective Criteria

Symptom

0 Grade

1 Grade

2 Grade

3 Grade

|Jrumbha

Never

Occasionally

Periodically

Always

|Angamarda

Never

Occasionally

Periodically

Always

|Tandra

Never

Occasionally

Periodically

Always

|Shirogaurav

Never

Occasionally

Periodically

Always

  1. Pittsburgh Sleep Quality Index (PSQI)

Statistical Analysis:

  1. All observation will be noted in the observation table.

  2. Depending upon observation, Statistical analysis will be done by appropriate test.

  3. Efficacy of Subjective criteria will be analyzed by Wilcoxon rank sum test.

  4. Efficacy of Objective criteria will be analyzed by paired t-test.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1-Patients complaining of difficulty in falling asleep, frequent or sustained awakenings and early morning awakenings.
  • 2-patients suffering from insomnia from one month or above.

排除标准

  • 1-Patients with major psychiatric illness like schizophrenia, depressive psychosis, epilepsy, etc 2-Patients with drug dependency.
  • 3-Women in their pregnancy and lactation.
  • 4-Chronic alcoholic patients.
  • 5-Diabetic patients.

结局指标

主要结局

The drug may help to bring Improvement in sleep Quality and duration

时间窗: total 28 days study | Follow up on 14th day 28th day & 14 days | after the completion of treatment.

次要结局

  • NA(NA)

研究者

发起方
Dr Tanya Bhawnani
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Tanya Bhawnani

Padmashree Dr DY Patil School of Ayurveda , Nerul ,Navi Mumbai

研究点 (1)

Loading locations...

相似试验